Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements

B H Ridha1, M R Symms, D J Tozer

  • 1Dementia Research Centre, Institute of Neurology, University College London, London, UK. bridha@dementia.ion.ucl.ac.uk

Abstract

Insights

Alzheimer disease (AD) shows reduced whole-brain (WB) volume and magnetization transfer ratio (MTR), indicating macrostructural and microstructural brain changes. These MRI measures independently differentiate AD patients from controls.

Area of Science:

  • Neurology
  • Radiology
  • Biomedical Imaging

Background:

  • Alzheimer disease (AD) is characterized by brain atrophy visible on MRI.
  • Magnetization transfer ratio (MTR) may reveal microstructural changes in AD.

Purpose of the Study:

  • To evaluate if MTR measurements, alongside volumetric MRI, can distinguish AD patients from healthy controls.
  • To explore the relationship between MRI parameters and cognitive function in AD.

Main Methods:

  • Volumetric T1-weighted MRI and 3D MTR maps were acquired from 18 AD patients and 18 controls.
  • Whole-brain (WB) and hippocampal (Hc) volumes were measured. Mean MTR for WB and Hc was calculated.
  • WB MTR histogram analysis and correlations with Mini-Mental State Examination (MMSE) scores were performed.

Main Results:

  • AD patients exhibited significantly reduced WB volume, WB MTR, Hc volume, and Hc MTR compared to controls.
  • WB volume and mean MTR independently predicted AD status.
  • Hc MTR did not add significant discriminatory value beyond Hc volume.

Conclusions:

  • Both WB volume and mean MTR are independently reduced in AD, reflecting macrostructural and microstructural damage.
  • These complementary MRI parameters offer insights into AD pathology.